Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.54 - $3.71 $109,229 - $263,142
-70,928 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $147,390 - $223,370
57,128 Added 413.97%
70,928 $189,000
Q3 2021

Nov 15, 2021

SELL
$2.77 - $4.05 $1.08 Million - $1.58 Million
-390,555 Reduced 96.59%
13,800 $47,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $691,447 - $1.67 Million
404,355 New
404,355 $1.55 Million
Q1 2021

May 17, 2021

SELL
$0.85 - $5.27 $202,005 - $1.25 Million
-237,654 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$0.36 - $0.95 $85,555 - $225,771
237,654 New
237,654 $207,000
Q3 2020

Nov 16, 2020

SELL
$0.36 - $0.53 $4,236 - $6,237
-11,769 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$0.39 - $0.69 $24,113 - $42,662
-61,830 Reduced 84.01%
11,769 $5,000
Q1 2020

May 15, 2020

BUY
$0.56 - $1.62 $41,215 - $119,230
73,599 New
73,599 $47,000
Q4 2019

Feb 14, 2020

SELL
$0.83 - $1.3 $11,936 - $18,695
-14,381 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$0.97 - $1.94 $13,949 - $27,899
14,381 New
14,381 $14,000
Q2 2019

Aug 14, 2019

SELL
$1.81 - $2.45 $27,678 - $37,465
-15,292 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$2.3 - $3.27 $35,171 - $50,004
15,292 New
15,292 $37,000
Q3 2018

Nov 14, 2018

SELL
$3.4 - $4.84 $651,559 - $927,513
-191,635 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.03 - $4.98 $580,654 - $954,342
191,635 New
191,635 $788,000
Q4 2017

Feb 14, 2018

SELL
$2.43 - $3.54 $129,341 - $188,423
-53,227 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$2.22 - $3.2 $118,163 - $170,326
53,227
53,227 $170,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $186M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.